Literature DB >> 15389488

Fluorescent peptide probes for in vivo diagnostic imaging.

Ching-Hsuan Tung1.   

Abstract

Recently, many novel peptide-based near-infrared (NIR) fluorescent molecular probes have been developed for in vivo biomedical imaging. To report specific information of biological targets, the probes were individually designed according to the unique property or functions of their targets. These peptide-based probes can be classified into targeting, crosslinking, and enzyme-activatable probes. Several of them have been tested in various in vitro and in vivo models, and the obtained imaging information has been applied to disease detection, medical diagnosis, and drug evaluations. (c) 2004 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2004        PMID: 15389488     DOI: 10.1002/bip.20139

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  43 in total

Review 1.  Advances in cardiovascular molecular imaging for tracking stem cell therapy.

Authors:  Katherine J Ransohoff; Joseph C Wu
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

2.  Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.

Authors:  Wael R Abd-Elgaliel; Zobeida Cruz-Monserrate; Craig D Logsdon; Ching-Hsuan Tung
Journal:  Mol Biosyst       Date:  2011-09-20

Review 3.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

4.  Near-infrared fluorescence imaging of apoptotic neuronal cell death in a live animal model of prion disease.

Authors:  Victoria A Lawson; Cathryn L Haigh; Blaine Roberts; Vijaya B Kenche; Helen M J Klemm; Colin L Masters; Steven J Collins; Kevin J Barnham; Simon C Drew
Journal:  ACS Chem Neurosci       Date:  2010-09-30       Impact factor: 4.418

5.  Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.

Authors:  Zhen Cheng; Yun Wu; Zhengming Xiong; Sanjiv Sam Gambhir; Xiaoyuan Chen
Journal:  Bioconjug Chem       Date:  2005 Nov-Dec       Impact factor: 4.774

6.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

Review 7.  New cast for a new era: preclinical cancer drug development revisited.

Authors:  Grit S Herter-Sprie; Andrew L Kung; Kwok-Kin Wong
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 8.  Fluorescent molecular imaging: technical progress and current preclinical and clinical applications in urogynecologic diseases.

Authors:  V M Alexander; P L Choyke; H Kobayashi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 9.  Cell tracking with optical imaging.

Authors:  Elizabeth J Sutton; Tobias D Henning; Bernd J Pichler; Christoph Bremer; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2008-05-28       Impact factor: 5.315

10.  Pronase E-Based Generation of Fluorescent Peptide Fragments: Tracking Intracellular Peptide Fate in Single Cells.

Authors:  Emilie R Mainz; Nicholas C Dobes; Nancy L Allbritton
Journal:  Anal Chem       Date:  2015-07-24       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.